Home/Capabilities/Regulatory excellence/Publishing and submission
Regulatory excellence
Publishing and submission
The step where every earlier decision is finally reconciled — and where a latent inconsistency becomes a validation error with no schedule left.
Why it matters
Publishing is a control function, not a formatting task
A submission that fails technical validation has not been assessed at all. A lifecycle that loses its sequence integrity becomes progressively harder to maintain, and the cost compounds silently for years.
Publishing is often the last thing planned and the first thing compressed. That is precisely backwards: it is the step where every earlier decision is finally reconciled, and where an inconsistency that has been latent for months becomes a validation error at the point of no remaining schedule.
Done properly it is invisible. Done badly it is the reason a filing date slips by a fortnight for reasons nobody can explain to the board.
Structure
Getting the lifecycle right the first time
The decisions that determine whether a dossier is maintainable are taken in the first sequence, not the fiftieth.
Dossier planning
Granularity, document naming and reuse strategy set before authoring begins, so the same content can serve several markets without rework.
Module 1 authoring
Region-specific administrative content, application forms and the supporting documentation each authority requires.
Sequence and lifecycle operations
Correct lifecycle operators across sequences, so the current view of the dossier is always accurate and reconstructable.
Technical validation
Validation against the applicable regional criteria before submission, with errors resolved rather than waived at the deadline.
Gateway and portal submission
Transmission through the applicable electronic route for each region, with acknowledgement tracked to receipt.
Remediation
Assessment and repair of legacy or inherited dossiers whose lifecycle integrity has broken down, typically after an acquisition.
Routes
Different destinations, different rules
The core content may be common. The submission requirements are not.
FDA
Electronic submission through the agency gateway, with regional Module 1 requirements and its own validation criteria and study data standards.
EMA and national
Centralised submissions through the applicable EU portal, and national or decentralised routes with their own regional requirements.
Other markets
Varying maturity — some fully electronic, some accepting eCTD alongside paper or portal-based routes, some still requiring locally formatted dossiers.
Reference-based routes
Where an authority relies on a reference approval, the submitted dossier must demonstrably match what that authority assessed.
Because requirements diverge, the discipline that matters is knowing exactly what was submitted where, and in what version. That is a records problem as much as a publishing one, and it is the reason we treat publishing and regulatory information management as the same conversation.
What we do
How we work on submissions
Plan the submission
Scope, structure, granularity and reuse agreed before authoring, with the target markets known.
Build and compile
Assemble content against the agreed structure, resolving inconsistencies as they surface rather than at the end.
Validate early and often
Run technical validation during compilation, not as a final gate — an error found on the last day is a schedule problem.
Submit and confirm
Transmit through the correct route, track acknowledgement, and record what was sent where.
Maintain the lifecycle
Keep sequences correct so the dossier stays reconstructable for as long as the product is registered.
Bring us the challenge
Where are you in this, right now?
The most useful conversations start with the specific decision or deadline in front of you, not with a service category.